The Indian pharma market (IPM) grew 15.3% YoY to INR 96.4bn in Aug?16, bolstered by superior growth in seasonal therapies like Anti-infective, Acute Respiratory and Gastro-intestinal. The performance has been encouraging amidst prevailing confusion over FDC products and frequent changes in NLEM list.